- Home
- DMRA vs REX Comparison
DMRA vs REX Comparison
Compare DMRA & REX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DMRA | REX |
|---|---|---|
| Founded | 2011 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | DMRA | REX |
|---|---|---|
| Price | $21.33 | $39.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $46.89 | N/A |
| AVG Volume (30 Days) | ★ 425.0K | 210.7K |
| Earning Date | 11-05-2026 | 12-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 121.48 | N/A |
| EPS | N/A | ★ 1.62 |
| Revenue | N/A | ★ $650,487,000.00 |
| Revenue This Year | N/A | $18.22 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $24.58 |
| Revenue Growth | N/A | ★ 1.24 |
| 52 Week Low | $16.50 | $31.00 |
| 52 Week High | $34.89 | $53.36 |
Technical Indicators
Market Signals| Indicator | DMRA | REX |
|---|---|---|
| Relative Strength Index (RSI) | 48.77 | 35.42 |
| Support Level | $17.69 | $39.04 |
| Resistance Level | $21.86 | $44.82 |
| Average True Range (ATR) | 1.35 | 1.37 |
| MACD | 0.51 | -0.31 |
| Stochastic Oscillator | 71.75 | 4.40 |
Price Performance
Historical ComparisonAbout DMRA Damora Therapeutics Inc. Common Stock
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
About REX REX American Resources Corporation
REX American Resources Corp operates as a holding company that engages in investments in alternative energy and ethanol production entities. Its operating segments include Ethanol and By-Products. Its products include Ethanol, dried distillers grains, modified distillers grains, Distillers corn oil, Modified distillers grains, and Other.